Joshua Makower, 10% Owner at Regulus Therapeutics Inc. (RGLS), bought 8,797,204 shares at $0.62 ($5.5M) on 2020-12-04, disclosed to the SEC on 2020-12-07.
Open-market purchase of $5.5M RGLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 4,398,602 | $2.7M | 50.0% |
| 2 | $0.62 | 4,398,602 | $2.7M | 50.0% |
| Total | $0.62 avg | 8,797,204 | $5.5M | 100% |
| Filing → |
| MRKR | BUY | 2021-03-18 | $20.0M | — | Filing → |
| EAR | BUY | 2020-10-22 | $5.6M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $10.0M | — | Filing → |